Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

Polymorphisms in the Lipopolysaccharide-Binding Protein and Bactericidal/Permeability-Increasing Protein in Patients with Myocardial Infarction

Jaroslav A. Hubacek / Jan Pitha / Zdena Skodová / Vera AdámkovÁ / Ivana Podrapska / Gerd Schmitz / Rudolf Poledne

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 40, Issue 11, Pages 1097–1100, ISSN (Print) 1434-6621, DOI: 10.1515/cclm.2002.191, June 2005

Publication History

Published Online:
2005-06-01

Abstract

Gram-negative bacterial infection, namely Chlamydia pneumoniae has been recently discussed as a risk factor for myocardial infarction. The lipopolysaccharide-binding protein (LBP) and the bactericidal/permeability-increasing protein (BPI) play a role in the processes leading to recognition and neutralisation of the Chlamydia pneumoniae and their endotoxins – lipopolysaccharides (LPS). LPS interact with plasma LBP, and LBP-LPS complex activates monocytes/ macrophages, which can influence the atherosclerotic process. BPI is cytotoxic for Gram-negative bacteria and BPI-LPS complexes do not activate monocytes. We have analysed the polymorphisms in the LBP gene (Gly98→Cys; Pro436→Leu) and BPI gene (Lys216→Glu; PstI polymorphism in intron-5; G545→C) in 313 patients after myocardial infarction (MI) and in 302 control individuals. Genotype frequencies in the LBP gene and BPI gene did not differ between MI patients and control individuals. Our findings suggest that LBP and BPI polymorphisms do not influence the risk of MI.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Q. Zhan, M. Yuan, X. H. Wang, X. M. Duan, Q. D. Yang, and J. Xia
Journal of Thrombosis and Thrombolysis, 2012, Volume 34, Number 2, Page 260
[2]
José María Moreno-Navarrete and José Manuel Fernández-Real
Expert Review of Clinical Immunology, 2014, Volume 10, Number 7, Page 855
[3]
Jana K. Eckert, Young J. Kim, Jung I. Kim, Kathleen Gürtler, Djin-Ye Oh, Saubashya Sur, Linn Lundvall, Lutz Hamann, Anke van der Ploeg, Peter Pickkers, Evangelos Giamarellos-Bourboulis, Andriy V. Kubarenko, Alexander N. Weber, Michael Kabesch, Oliver Kumpf, Hyun-Jung An, Jie-Oh Lee, and Ralf R. Schumann
Immunity, 2013, Volume 39, Number 4, Page 647
[4]
P.-H. Ding and L.J. Jin
Journal of Periodontal Research, 2014, Volume 49, Number 1, Page 1
[5]
Ling Zeng, Wei Gu, An-qiang Zhang, Mao Zhang, Lian-yang Zhang, Ding-yuan Du, Su-na Huang, and Jian-Xin Jiang
Annals of Surgery, 2012, Volume 255, Number 1, Page 147
[6]
[7]
Richard G. Wunderink and Grant W. Waterer
Infectious Disease Clinics of North America, 2004, Volume 18, Number 4, Page 743
[8]
Taina Korhonen, Silke Grauling-Halama, Niels Halama, Sylvi Silvennoinen-Kassinen, Maija Leinonen, and Pekka Saikku
Journal of Immunological Methods, 2006, Volume 317, Number 1-2, Page 171
[9]
Ralf R. Schumann
Biochemical Society Transactions, 2011, Volume 39, Number 4, Page 989
[10]
Helga-Paula Török, Jürgen Glas, Laurian Tonenchi, Thomas Mussack, and Christian Folwaczny
Clinical Immunology, 2004, Volume 112, Number 1, Page 85
[11]
Richard G. Wunderink and Grant W. Waterer
Current Opinion in Critical Care, 2003, Volume 9, Number 5, Page 384
[12]
Nicolas WJ Schröder and Ralf R Schumann
The Lancet Infectious Diseases, 2005, Volume 5, Number 3, Page 156
[14]
K. Poikonen, T. Lajunen, S. Silvennoinen-Kassinen, M. Leinonen, and P. Saikku
Scandinavian Journal of Immunology, 2009, Volume 70, Number 1, Page 34
[15]
Jaroslav Michalek, Petra Svetlikova, Michal Fedora, Michal Klimovic, Lenka Klapacova, Drahomira Bartosova, Lubomir Elbl, Hana Hrstkova, and Jaroslav A. Hubacek
Intensive Care Medicine, 2007, Volume 33, Number 12, Page 2158
[16]
J. Glas, H.-P. Torok, L. Tonenchi, S. Hamann, O. Malachova, A. Euba, C. Folwaczny, and M. Folwaczny
International Journal of Immunogenetics, 2006, Volume 33, Number 4, Page 255
[17]
Wolfram Klein, Andreas Tromm, Christian Folwaczny, Michaela Hagedorn, Natascha Duerig, Joerg Epplen, Wolff Schmiegel, and Thomas Griga
Journal of Clinical Gastroenterology, 2005, Volume 39, Number 4, Page 282

Comments (0)

Please log in or register to comment.